HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of acute inflammation by targeting glycosaminoglycan-cytokine interactions.

Abstract
Glycosaminoglycans (GAGs) located on cellular membranes and the extracellular matrix (ECM) are able to interact with chemokines and pro-inflammatory cytokines, leading to local cytokine/chemokine accumulation. The tissue-bound cytokines/chemokines function in promoting leukocyte migration and activation, contributing to local inflammation. Hence, targeting of GAG-cytokine interactions may provide an avenue for the attenuation of inflammatory responses. A cationic peptide (MC2) derived from the heparin-binding sequence of mouse IFN-gamma was previously shown by our laboratory to delay allograft rejection in an animal model. In order to further investigate potential anti-inflammatory properties of the MC2 peptide, we have studied its activity in an acute peritoneal inflammation model. Groups of C57Bl/6 mice were injected intraperitoneally with either ConA or thioglycollate and treated with saline (control), the MC2 peptide or two control cationic peptides, poly-l-lysine (PLL) and poly-l-arginine (PLA). Treatment with the MC2 peptide, but not PLA or PLL, resulted in statistically significant reductions in total cell numbers, concentration of total proteins and concentrations of pro-inflammatory cytokines (TNFalpha, IL-6 or IL-1 beta) in peritoneal lavage fluids, without alterations to the qualitative cellular composition of the exudate. These results suggest that targeting GAG-cytokine interaction is a viable approach to reduce inflammation.
AuthorsJames G Cripps, Fabián A Crespo, Peteris Romanovskis, Arno F Spatola, Rafael Fernández-Botrán
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 5 Issue 11 Pg. 1622-32 (Oct 2005) ISSN: 1567-5769 [Print] Netherlands
PMID16039552 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Cytokines
  • Glycosaminoglycans
  • MC2 peptide
  • MC2 protein, mouse
  • Peptide Fragments
  • Proteins
  • Thioglycolates
  • Concanavalin A
  • Interferon-gamma
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Apoptosis (drug effects)
  • Ascitic Fluid (cytology, metabolism)
  • Cells, Cultured
  • Concanavalin A
  • Cytokines (metabolism, physiology)
  • Female
  • Glycosaminoglycans (metabolism, physiology)
  • Inflammation (chemically induced, drug therapy, metabolism)
  • Interferon-gamma (pharmacology)
  • Mice
  • Mice, Inbred C57BL
  • Peptide Fragments (pharmacology)
  • Proteins (pharmacology)
  • Thioglycolates

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: